Showing results (1541-1550 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|March 21, 2000
Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantationD W van BekkumBone Marrow Transplantation|March 21, 2000
The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemiaJ L Byrne, C Stainer, G Cull, et al.Bone Marrow Transplantation|March 21, 2000
The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell doseD A Stewart, D Guo, J Luider, et al.Bone Marrow Transplantation|August 10, 2000
New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cellsE K Waller, M BoyerBone Marrow Transplantation|August 10, 2000
Treatment of patients with malignant lymphomas with monoclonal antibodiesH Tesch, A Engert, O Manzke, et al.Bone Marrow Transplantation|August 10, 2000
Unrelated cord blood transplantation vs matched unrelated donor bone marrow transplantation: the risks and benefits of each choiceM J MogulBone Marrow Transplantation|August 10, 2000
Evaluation of engraftment of ex vivo expanded cord blood cells in humansM N Fernández, A Grañena, I Millán, et al.Bone Marrow Transplantation|August 10, 2000
Genetic modification of haematopoietic cells for combined resistance to podophyllotoxins, other agents covered by MDR1-mediated efflux activity and nitrosoureasC Baum, S Peinert, A Carpinteiro, et al.Bone Marrow Transplantation|August 10, 2000
Allogeneic vaccination for renal cell carcinoma: development and monitoringH Pohla, B Frankenberger, B Stadlbauer, et al.Bone Marrow Transplantation|August 10, 2000
Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantationK Kühlcke, F A Ayuk, Z Li, et al.Pageof 993